Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Brandýs nad Labem
Clinical trial register · Czechia

Clinical Trials in Brandýs nad Labem, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Czechia and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 1529 matching records held by the registry are in this view. Synced 18 Nov 2026, 03:17 UTC
1529
Studies in scope
all four open statuses
792
Recruiting now
open to new participants
306
Lead sponsors
across recruiting studies
Top sites
Prague 1092 Brno 613 Hradec Králové 324 Olomouc 315 Ostrava 286

Trials with a site in Brandýs nad Labem

30 of 1529 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Czechia
Start
Not yet open
Novo Nordisk A/S
Phase 3
8,500
Brandýs nad Labem, Brno, Broumov, Chlumec nad Cidlinou, Chrudim, České Budějovice, Hodonín, Humpolec
2026-10-26
Recruiting
AstraZeneca
Phase 3
2,500
Benešov, Brandýs nad Labem, Brno, Hodonín, Kladno, Ostrava, Prague, Štětí
2026-08-19
Active, closed
Novartis Pharmaceuticals
Phase 3
5,700
Kroměříž, Louny, Ostrava, Ústí nad Labem, Brandýs nad Labem, Brno, Broumov, Chlumec nad Cidlinou
2026-05-11
Recruiting
Novo Nordisk A/S
Phase 3
5,610
Benešov, Brandýs nad Labem, Brno, Brno - Sever, Broumov, Česká Třebová, Dolní Břežany, Jihlava
2026-05-11
Recruiting
Hoffmann-La Roche
Phase 3
1,600
Brandýs nad Labem, Jesenice, Prague, Praha 9 - Klánovice
2026-03-23
Active, closed
Kailera
Phase 3
1,270
Brandýs nad Labem, Náchod, Trutnov, Bohnice, Prague, Brno, Holešov, Hodonín
2026-01-12
Active, closed
Kailera
Phase 3
2,530
Brandýs nad Labem, Náchod, Krnov, Bohnice, Prague, Brno, Hodonín, Olomouc
2025-12-18
Recruiting
Eli Lilly and Company
Phase 3
7,140
Brandýs nad Labem, Chlumec nad Cidlinou, České Budějovice, Havířov, Jablonec nad Nisou, Jílové u Prahy, Krnov, Ostrava
2025-12-01
Recruiting
Boehringer Ingelheim
Phase 3
11,800
Brandýs nad Labem, Brno, Havířov, Prague, Uherské Hradiště, Znojmo
2025-07-22
Active, closed
Upstream Bio Inc.
Phase 2
666
Broumov, Poruba, Prague, Rokycany, Miroslav, Brandýs nad Labem, Kralupy nad Vltavou, Teplice
2025-07-02
Recruiting
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
NCT07037459Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction, Obesity
Amgen
Phase 3
5,056
Brandýs nad Labem, Brno, Broumov, Bruntál, Chlumec nad Cidlinou, Chomutov, Havirov - Mesto, Holešov
2025-06-25
Active, closed
AstraZeneca
Phase 3
3,103
Benešov, Brandýs nad Labem, Chlumec nad Cidlinou, České Budějovice, Hodonín, Jílové u Prahy, Klatovy, Prague
2025-05-28
Recruiting
Boehringer Ingelheim
Phase 3
4,200
Bílovec, Brandýs nad Labem, Brno, Jaroměř, Litovel, Louny, Mariánské Lázně, Olomouc
2025-05-20
Recruiting
Pfizer
Phase 2
252
Brandýs nad Labem, Jindrichuv Hradec III, Hradec Králové, Lovosice
2025-05-20
Recruiting
AstraZeneca
Phase 3
990
Brandýs nad Labem, Brno, Jindřichův Hradec, Lovosice, Pilsen, Prague, Teplice, Varnsdorf
2025-03-18
Recruiting
AstraZeneca
Phase 3
11,300
Benešov, Brandýs nad Labem, Brno, Chlumec nad Cidlinou, Hodonín, Humpolec, Jaroměř, Jílové u Prahy
2025-03-14
Active, closed
Amgen
Phase 3
3,853
Brandýs nad Labem, Brno, Havířov, Olomouc, Ostrava, Prague
2025-03-12
Recruiting
AstraZeneca
Phase 3
5,000
Brandýs nad Labem, Frýdek-Místek, Jilemnice, Krnov, Mladá Boleslav, Náchod, Olomouc, Pilsen
2025-03-03
Active, closed
GlaxoSmithKline
Phase 2
307
Brandýs nad Labem, Mladá Boleslav, Teplice
2025-02-10
Recruiting
Boehringer Ingelheim
Phase 3
6,712
Bílovec, Brandýs nad Labem, Brno, Chrudim, Havlíčkův Brod, Jablonec nad Nisou, Jihlava, Litovel
2024-06-17
Active, closed
Eli Lilly and Company
Phase 3
10,000
Brandýs nad Labem, Brno, Chlumec nad Cidlinou, Český Krumlov, Holešov, Kolín, Litovel, Náchod
2024-04-30
Active, closed
Eli Lilly and Company
Phase 3
17,300
Brandýs nad Labem, Brno, Litovel, Náchod, Olomouc, Ostrava, Prague, Říčany
2024-03-05
Recruiting
AstraZeneca
Phase 3
5,250
Brandýs nad Labem, Jindřichův Hradec, Olomouc, Ostrava, Prague, Rokycany, Tábor
2024-02-21
Active, closed
Janssen Research & Development, LLC
Phase 3
20,284
Bílovec, Brandýs nad Labem, Brno, Broumov, Chomutov, Chrudim, České Budějovice, Jablonec nad Nisou
2023-04-11
Active, closed
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
NCT05739383Primary Prevention of Atherosclerotic Cardiovascular Disease
Novartis Pharmaceuticals
Phase 3
14,012
Louny, Ostrava, Ústí nad Labem, Přerov, Brandýs nad Labem, Brno, Chlumec nad Cidlinou, Český Krumlov
2023-03-09
Recruiting
Anthos Therapeutics, Inc.
Phase 3
2,500
Brandýs nad Labem, Liberec, Ostrava - Poruba, Poděbrady, Prague, Trutnov, Ústí nad Labem
2022-12-27
Active, closed
Ionis Pharmaceuticals, Inc.
Phase 3
885
Brandýs nad Labem, Hradec Králové, Louny, Náchod, Ostrava, Prague, Příbram, Teplice
2022-12-13
Active, closed
Eli Lilly and Company
Phase 3
15,374
Brandýs nad Labem, Český Krumlov, Havířov, Hodonín, Jindřichův Hradec, Olomouc, Ostrava, Prague
2022-10-11
Active, closed
NewAmsterdam Pharma
Phase 3
9,541
Bílina, Brandýs nad Labem, Brno, Havlíčkův Brod, Hodonín, Krnov, Kroměříž, Liberec
2022-02-07
Active, closed
Anthos Therapeutics, Inc.
Phase 2
1,287
Brandýs nad Labem, Poděbrady, Příbram, Slaný, Mariánské Lázně, Trutnov, Liberec, Česká Lípa
2021-02-02
Rows per page Showing 1–30 of 30
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Czech investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 18 November 2026. https://priyalifescience.com/clinical-trials-czechia/city/brand-s-nad-labem

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Czechia and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 1,529 studies in total at the last sync on 18 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 30 of those studies with a site in Brandýs nad Labem.

How many clinical trials are recruiting in Brandýs nad Labem?

14 of the 30 studies on this page are recruiting new participants as of the 18 Nov 2026, 03:17 UTC sync. A further 1 have not yet opened recruitment, 15 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Brandýs nad Labem), 30 studies
PhaseStudiesRecruitingShare
Phase 3261386.7%
Phase 24113.3%

Most active sponsors

Lead sponsors with the most studies (Brandýs nad Labem)
Lead sponsorStudiesRecruiting
AstraZeneca65
Eli Lilly and Company41
Boehringer Ingelheim33
Amgen21
Anthos Therapeutics, Inc.21
Kailera20
Novartis Pharmaceuticals20
Novo Nordisk A/S21
GlaxoSmithKline10
Hoffmann-La Roche11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.